Blue Cross Blue Shield Iowa pneumatic compression Coverage

Coverage and Medical Necessity Criteria

inv-01: Lymphedema Nonprogrammable Pumps - Initial coverage

Covered when ALL of the following are met:

Lymphedema nonprogrammable pump criteria: Nonprogrammable/non-self-calibrated pneumatic compression device home use applied to the limb may be considered medically necessary when lymphedema has failed to respond to a four-week trial of conservative therapy with documented compliance to: (1) use of an appropriate compression bandage or compression garment providing 30 mmHg; (2) exercise; (3) elevation of the affected limb; and (4) the treating physician documents there has been no significant improvement based on circumference measures and significant symptoms remain after the trial of conservative therapy.4 weeks; 30 mmHg

inv-02: Lymphedema Programmable Pumps - Coverage

Covered when ANY of the following are met:

Programmable pump criteria: Programmable/self-calibrated pneumatic compression devices home use applied to the limb may be considered medically necessary when the individual's condition has failed to respond to therapy using non-programmable pneumatic compression devices; OR there is clear documentation of unique characteristics preventing satisfactory pneumatic compression treatment using non-programmable devices (eg, significant scarring, fibrosis, contractures).

Intended for a small subset of individuals.

inv-03: Postsurgical Home Use for VTE Prophylaxis - Medically Necessary

Covered when ALL of the following are met:

Postsurgical IPC with contraindication to anticoagulation: Intermittent or non-programmable limb compression devices for home use may be considered medically necessary for VTE prophylaxis when the individual has a contraindication to pharmacologic agent(s) AND is in one of the following situations: after major orthopedic surgery (total hip arthroplasty, total knee arthroplasty, hip fracture surgery); OR after major non-orthopedic surgery or other orthopedic procedures in individuals who are at moderate or high risk of VTE as defined by risk factors (eg, age >65, previous bleeding, cancer, metastatic cancer, renal failure, liver failure, thrombocytopenia, previous stroke, diabetes, anemia, antiplatelet therapy, poor anticoagulant control, comorbidity with reduced functional capacity, recent surgery, frequent falls, alcohol abuse, NSAID use).contraindication to pharmacologic prophylaxis

References ACCP guidance for bleeding risk factors.

inv-04: Indications and device selection

Covered when ALL of the following are met (context from document):

General coverage context: PCPs are used as adjunctive therapy for lymphedema, to supplement standard care for venous ulcers, or as mechanical prophylaxis for VTE when anticoagulation is contraindicated or not used.

Supported by background and device type descriptions.

Device selection: A non-segmented or segmented nonprogrammable device is generally sufficient; programmable/gradient devices are indicated when contractures, extensive scarring, or sensitive skin prevent adequate treatment with simpler devices.

Device selection guidance.

inv-05: VTE prophylaxis — duration and selection

Duration and use for VTE prophylaxis when selected instead of pharmacologic prophylaxis:

Orthopedic postoperative prophylaxis duration: Use of intermittent limb compression devices for 10 to 14 days after major orthopedic surgery is consistent with ACCP guidance.10-14 days

Portion may be post-discharge home use.

Device portability and daily use: If limb compression devices are chosen for home thromboprophylaxis, devices should be portable/battery-operated and used approximately 18 hours per day.~18 hours/day

Compliance concerns favor portable devices.

Reason to choose mechanical over pharmacologic: Mechanical prophylaxis may be chosen when pharmacologic prophylaxis is contraindicated due to increased bleeding risk or intolerance.

inv-06: Clinical coverage considerations and evidence summary

Coverage considerations and clinical justification referenced in the evidence and guidelines:

VTE prophylaxis for major orthopedic surgery: ACCP recommends pharmacologic prophylaxis (or mechanical prophylaxis) rather than no thromboprophylaxis for individuals undergoing major orthopedic surgery; a minimum of 10-14 days of prophylaxis is recommended, a portion of which can be post-discharge home use.duration >= 10 days

Portable IPC may be considered as adjunct; documentation of indication and device clearance recommended.

Nonorthopedic surgery prophylaxis: For general or abdominal-pelvic surgery with VTE risk >=3%, provide pharmacologic agents or IPC; for low risk (~1.5%), mechanical prophylaxis is suggested. Extended pharmacologic prophylaxis (4 weeks) is recommended only for high-risk cancer abdominal/pelvic surgery patients.VTE risk >= 3%

No general timeframe specified for nonorthopedic patients except definition of 'extended duration' = 4 weeks for specific high-risk cases.

inv-07: General medical necessity criteria for PCPs

Covered when ALL of the following are met

Primary criteria: 1) Clinical diagnosis of lymphedema; 2) Failure of conservative therapy (eg, exercise, compression, elevation, manual lymphatic drainage, complete decongestive therapy) documented; 3) Device application (limb-only, limb+trunk, or head/neck APCD) specified and clinically indicated; 4) Baseline measures (symptoms, limb volume/circumference, function) documented and plan for follow-up (>=6 weeks) provided.

Derived from clinical context and PICO statements in document.

inv-08: Lymphedema — limb and trunk/chest pneumatic compression

Covered when ALL of the following are met

Lymphedema: limb+trunk/chest pneumatic compression: Patient has documented lymphedema and has failed conservative therapy (eg, exercise, compression garments, elevation, manual lymphatic drainage); therapy is intended as alternative or adjunct to existing therapies; device use and training documented.

Evidence from two small RCTs does not demonstrate consistent incremental benefit of truncal treatment over limb-only treatment; approval may require demonstration of medical necessity versus limb-only devices.

inv-09: Postoperative VTE prophylaxis — home IPC

Covered when ALL of the following are met

Post-surgical VTE prophylaxis — adjunctive home IPC: Patient has moderate-to-high postsurgical risk of VTE and no contraindication to pharmacologic prophylaxis (for adjunctive use) OR has contraindication to pharmacologic prophylaxis (for mechanical-only prophylaxis); ordering clinician documents intended use, duration, and that this is post-discharge/home use.

No RCTs assess incremental benefit of home IPC plus pharmacologic agents; in-hospital evidence supports IPC plus pharmacologic prophylaxis for DVT prevention but may not generalize to home setting.

inv-10: Post-discharge IPC for patients with contraindication to pharmacologic prophylaxis

Covered when ALL of the following are met

Home IPC for VTE prophylaxis after surgery: Patient has moderate-to-high postsurgical risk of VTE AND has a contraindication to pharmacologic prophylaxis AND home IPC is intended as adjunct/alternative to no outpatient pharmacologic prophylaxis; a clinical plan for home use including measures to support compliance (eg, home visits) or other documented feasibility measures must be provided.

Evidence for benefit in home setting is limited; one RCT showed benefit with home visits to support compliance

inv-11: Other clinical indications (DFU, arterial insufficiency)

Covered/considered for other indications when supporting evidence exists and clinical criteria are met

Other indications (DFU, peripheral arterial disease, claudication): Use of IPC or compressed air massage for diabetic foot ulcers (DFU) or intermittent claudication may be considered when RCTs or systematic reviews demonstrate improved healing or functional outcomes and when standard care has been provided; document wound status, prior standard wound care, expected regimen, and compliance monitoring.

Quality of evidence variable; some RCTs show benefit dependent on compliance

inv-12: Evidence summaries by indication

Evidence summary and implications for coverage of IPC/PCD for various non‑VTE indications:

Diabetic foot ulcers (DFU): Two RCTs and systematic reviews suggest IPC and compressed air massage can improve time to healing; one higher‑quality RCT showed IPC had a significant advantage over placebo with 75% healed at 12 weeks (100% in compliant patients) though overall consensus is limited given only one good-quality trial.

Evidence limited to IPC and compressed air massage; no cost-effectiveness data

Post‑reconstructive edema (femoropopliteal bypass): An RCT found class I compression stockings were superior to IPC for prevention/treatment of postoperative edema following femoropopliteal bypass surgery.

Stockings recommended

Fracture and soft‑tissue healing: Small studies and case series suggest IPC may facilitate fracture and soft tissue healing but RCTs are small and inadequately powered; stronger RCTs are needed.

Evidence preliminary

inv-13: Coverage criteria summarizing guideline-based indications

Covered when recommendations from specialty guidelines are met and documented:

Surgical VTE prophylaxis: IPC is supported as part of prophylaxis strategies depending on VTE and bleeding risk: use IPC as adjunct to pharmacologic prophylaxis in moderate-to-high VTE risk when not at high bleeding risk; use IPC alone when pharmacologic prophylaxis is contraindicated or bleeding risk is high; for major orthopedic surgery consider IPC during hospital stay and dual prophylaxis when appropriate.

Summarizes ACCP, ACOG, ASH guidance

Lymphedema management: Sequential/pneumatic compression is recommended or suggested for lymphedema patients, especially early stages or as part of home management and after fitting and referral to a certified lymphedema therapist; documentation of screening and referral is recommended.

Based on NCCN, American Venous Forum, UIP

Venous ulcer therapy: Intermittent pneumatic compression may be used when standard compression therapies are unavailable, cannot be used, or have failed, and can be used with or without compression dressings to aid venous ulcer healing.

inv-14: Guideline Recommendations

Guideline-based use statements summarized from professional societies

Venous leg ulcers (SVS/AVF): Use of intermittent pneumatic compression is suggested when other compression options are not available, cannot be used, or have failed to aid in venous leg ulcer healing after prolonged compression therapy.

Grade 2; Level of Evidence C

Venous ulcers (Wound Healing Society): Intermittent pneumatic pressure can be used with or without compression dressings and can provide another option in patients who cannot or will not use an adequate compression dressing system.

The policy identifies cooling devices and multiple non‑standard uses of pneumatic compression as investigational. Examples listed explicitly include diabetic neuropathic ulcers, peripheral artery disease/arterial insufficiency, truncal/chest treatment, head/neck applications in many situations, venous ulcers, fracture/soft‑tissue healing, and other uses where evidence is insufficient to determine a net health benefit.

The document states that a non‑segmented or segmented nonprogrammable device is generally sufficient for most patients. A segmented calibrated gradient pressure (programmable) device is typically indicated only when contractures or extensive scarring prevent satisfactory treatment with simpler devices; programmable pumps are therefore reserved for a small subset with specific anatomic barriers to effective nonprogrammable therapy.

For home thromboprophylaxis the ACCP guidance cited in the policy emphasizes limiting use to portable, battery‑operated devices because compliance is a major issue. The policy therefore discourages nonportable, non–battery‑operated limb compression devices for routine home use and recommends documenting that the device is appropriate for the home setting and FDA‑cleared for home care.

The policy notes uncertainty in the evidence base: studies of APCDs (head/neck) and other non‑standard uses often have high risk of bias, small samples, industry sponsorship, limited adherence, and inconsistent outcome measures. Consequently, the document does not list comprehensive explicit exclusions in this section but flags that limited quality and unclear optimal timing/duration/intensity of use should be considered when evaluating requests.

Two small RCTs assessing limb plus trunk/chest therapy (Flexitouch) produced inconsistent results: one trial reported benefits on some intermediate outcomes while the other found no significant differences. The policy therefore states that evidence does not demonstrate a consistent incremental benefit of truncal/chest treatment over limb‑only pumps and cautions that approval for truncal devices requires justification versus limb‑only options.

Meta‑analyses and RCTs demonstrating benefit of IPC were largely conducted in the in‑hospital setting. The policy cautions that inferences from inpatient trials do not automatically establish home benefit because discharged patients, adherence, application errors, and duration differ between settings; post‑discharge/home benefit therefore requires patient‑specific justification or supporting home‑use evidence.

Regarding diabetic foot ulcers and other non‑VTE indications, the policy recognizes limited evidence

The ACCP section observes that the efficacy of mobile mechanical compression devices as monotherapy has not been compared in adequately powered randomized trials to chemoprophylaxis, and raises concerns about post‑discharge compliance and device cost. The policy therefore treats provision of mobile mechanical compression as monotherapy without documented contraindication or plan for compliance as of uncertain efficacy.

Within the provided excerpts there are no comprehensive explicit coverage exclusions listed; instead the document highlights investigational indications and evidence limitations and notes ongoing/unpublished trials without specifying additional categorical exclusions.

HCPCS and Coding Guidance

Single compartment pumps (pump codes)HCPCSCovered

E0650

Pneumatic compressor, nonsegmental home model

Multi-chamber pumps (pump codes)HCPCSCovered

E0651

Pneumatic compressor, segmental home model without calibrated gradient pressure

Multi-chamber programmable pumps (pump codes)HCPCSCovered

E0652

Pneumatic compressor, segmental home model with calibrated gradient pressure

Appliance codes paired with E0650HCPCSCovered

E0655	Nonsegmental pneumatic appliance for use with pneumatic compressor, half arm
E0660	Nonsegmental pneumatic appliance for use with pneumatic compressor, full leg
E0665	Nonsegmental pneumatic appliance for use with pneumatic compressor, full arm
E0666	Nonsegmental pneumatic appliance for use with pneumatic compressor, half leg

Appliance codes paired with E0651HCPCSCovered

E0667	Segmental pneumatic appliance for use with pneumatic compressor, full leg
E0668	Segmental pneumatic appliance for use with pneumatic compressor, full arm
E0669	Segmental pneumatic appliance for use with pneumatic compressor, half leg

Appliance codes paired with E0652HCPCSCovered

E0671	Segmental gradient pressure pneumatic appliance, full leg
E0672	Segmental gradient pressure pneumatic appliance, full arm
E0673	Segmental gradient pressure pneumatic appliance, half leg

HCPCS Codes for Pneumatic Compression Devices and AppliancesHCPCSCovered

E0650	Pneumatic compressor, nonsegmental home model.
E0651	Pneumatic compressor, segmental home model without calibrated gradient pressure.
E0652	Pneumatic compressor, segmental home model with calibrated gradient pressure.
E0655	Nonsegmental pneumatic appliance for use with pneumatic compressor, half arm.
E0656	Segmental pneumatic appliance for use with pneumatic compressor, trunk.
E0657	Segmental pneumatic appliance for use with pneumatic compressor, chest.
E0658	Segmental pneumatic appliance for use with pneumatic compressor, integrated, 2 full arms and chest.
E0659	Segmental pneumatic appliance for use with pneumatic compressor, integrated, head, neck and chest.
E0660	Nonsegmental pneumatic appliance for use with pneumatic compressor, full leg.
E0665	Nonsegmental pneumatic appliance for use with pneumatic compressor, full arm.

1–10 of 20
1/2

Reporting guidancemixed

To report provider services, use appropriate CPT codes, HCPCS codes, Revenue codes, and/or ICD diagnosis codes.

Conservative therapy duration — 4 weeks

Required conservative therapy duration4 weeks of documented conservative therapy prior to approval

Required components of conservative therapyCompression garment or bandage providing 30 mmHg, exercise, and limb elevation

DocumentationTreating physician must document no significant improvement by circumference measures after 4 weeks

Compression garment pressure — 30 mmHg

Compression garment pressure30 mmHg required as part of documented conservative therapy

PurposeUsed as a benchmark for adequate conservative compression prior to pneumatic pump consideration

DocumentationMember compliance with 30 mmHg garment must be recorded in clinical notes

Caprini score risk groups — Scores and approximate VTE risks

Caprini score 1-2Low risk — ~1.5% symptomatic VTE

Caprini score 3-4Moderate risk — ~3% symptomatic VTE

Caprini score ≥5High risk — ~6% symptomatic VTE

Recommended session duration (Flexitouch in Ridner RCT)

Session duration range (Ridner RCT)23–45 minutes per session (varied by garment size)

Recommended frequencyTwice daily recommended in protocol, though adherence in trials was typically once daily or less

TrainingPatients were trained on device use and instructed on timing per garment size

Head and neck APCD typical session in studies

Typical session length in head & neck APCD studiesSingle 32-minute session per day in many studies

Study durationsIntervention durations varied from a single session to six months across studies

Adherence noteMost participants used one 32-minute session daily rather than the twice-daily regimen recommended in some protocols

Miscellaneous coding key-value placeholder (empty label)

ImportanceMedium — coding/context placeholder

NoteNo specific threshold value provided in source

Prior Authorization, Documentation, and Billing Actions

Note
PRIOR APPROVAL
Prior Approval — Prior authorization is not required for pneumatic compression devices in this policy.

Billing Rule
Code reporting requirement
HCPCS coding requirement — Claims must include one HCPCS code for the pump (E0650–E0652) and one for the appliance/sleeve (E0655–E0673 and related codes). Ensure appropriate pump and corresponding appliance codes are documented on the claim.
Report both pump and appliance HCPCS codes on the same claim (e.g., E0650 + E0660).
See full HCPCS list in coding section for appliance variations.

Documentation Required
Home-use device clearance and rationale
Home-use device clearance and rationale — Verify and document that the specific device requested is cleared for home use (FDA 510(k) product code JOW) and include the device model in the clinical record.
Confirm FDA 510(k) clearance (product code JOW) for the device model.
Document device model and rationale for home use in the medical record.

Prior Authorization
Prior authorization: conservative therapy prerequisite
Prior authorization: failure of conservative therapy required — For lymphedema therapy in the home, demonstrate a documented trial of conservative therapy (minimum four weeks) with compliance to all elements before considering home pneumatic compression.
Document a 4-week trial with compliance to: appropriate compression bandage/garment (providing ~30 mmHg), exercise, and limb elevation.
Treating physician must document no significant improvement based on circumference/volume measurements and persistent symptoms.
For programmable pumps, show prior failure of nonprogrammable device therapy or unique characteristics preventing benefit from simpler devices.

Prior Authorization
Prior authorization guidance for home IPC/PCD
Home IPC prior authorization requirements — When intermittent pneumatic compression (IPC) is requested for post‑discharge VTE prophylaxis or other home indications, prior authorization is recommended to confirm clinical appropriateness and feasibility.
For post‑discharge VTE prophylaxis, document moderate-to-high VTE risk and whether pharmacologic prophylaxis is contraindicated.
When pharmacologic prophylaxis is possible, IPC is generally adjunctive — monotherapy requires justification.
Confirm availability of post-discharge support to optimize adherence and device use.

Prior Authorization
Home IPC prior authorization requirements — postsurgical VTE
Prior authorization: postsurgical home VTE prophylaxis — For postsurgical home IPC for VTE prophylaxis, document that the patient is at moderate-to-high VTE risk and has a contraindication to pharmacologic prophylaxis (or provide rationale if IPC is proposed as monotherapy).
List surgical type (e.g., THA, TKA, hip fracture) and specific risk factors (age >65, cancer, renal failure, thrombocytopenia, prior bleeding, etc.).
Document the contraindication to anticoagulants (e.g., active bleeding, high bleeding risk, perioperative hemorrhage).
If IPC is requested as monotherapy, include explicit rationale and supporting guideline references.

Prior Authorization
Prior authorization recommended for non‑VTE home IPC/PCD
Prior authorization recommended when IPC/PCD requested for non‑VTE home indications — Because evidence for home use in many non‑VTE indications is limited, prior authorization is recommended to review indication, prior standard care, and expected benefit.
Provide indication (e.g., lymphedema, venous ulcer, wound adjunct) and prior conservative care attempted.
Document objective wound/limb measurements and planned duration of therapy.
Justify need for home device versus clinic-based therapy.

Prior Authorization
Prior authorization recommended when IPC is monotherapy
Prior authorization recommended when IPC used as monotherapy — If IPC is proposed instead of pharmacologic prophylaxis, document why pharmacologic agents cannot be used and provide clinical justification for mechanical-only prophylaxis.
Cite bleeding risk assessment or explicit contraindication to anticoagulation.
Reference guidance that mechanical-only prophylaxis may be appropriate when bleeding risk is high.
Include plan for monitoring and follow-up.

Note
Bleeding risk may preclude anticoagulants
Bleeding risk and contraindications — Patients with high bleeding risk or active bleeding may be unable to receive pharmacologic prophylaxis; document bleeding risk assessment when considering IPC as an alternative.
Assess and document bleeding risk (e.g., HAS-BLED or clinical rationale).
If bleeding risk precludes anticoagulants, record the specific bleeding risk factors that led to choosing mechanical prophylaxis.

Note
Compliance and device portability
Compliance and device portability — Home use feasibility depends on patient adherence; portable, battery-operated devices are preferred for outpatient prophylaxis and should be considered when post-discharge compliance is a concern.
Document device portability and battery operation when used for home VTE prophylaxis.
Note that ACCP recommends portable devices and long daily wear times (e.g., ~18 hours/day) for outpatient use.

Denial Risk
Adherence and access issues may affect authorization
Adherence and access issues may affect authorization — Low adherence in studies and difficulties obtaining certain advanced devices can influence coverage decisions; document expected adherence plan and access arrangements.
Provide a plan for device training, home observation, and follow-up to support adherence.
Document barriers to access (e.g., device availability, cost) and mitigation strategies.

Denial Risk
Lack of demonstrated incremental benefit / Evidence limitations
Evidence limitations and lack of demonstrated incremental benefit — There is limited or mixed evidence for incremental benefit of trunk/chest devices over limb-only devices and few RCTs supporting post‑discharge addition of IPC to pharmacologic prophylaxis; this uncertainty may lead to denial if benefit is not documented.
Document why a truncal/chest device is needed vs. limb-only therapy when applicable.
Recognize that inpatient trial results may not generalize to the home setting; provide supporting evidence when requesting home use.

Denial Risk
No post-discharge RCT evidence for adjunctive home IPC
No post‑discharge RCT evidence for adjunctive home IPC plus pharmacologic prophylaxis — RCT evidence of added benefit for home IPC when pharmacologic prophylaxis is used post‑discharge is lacking; claims should justify extrapolation from inpatient data and include plans to address home-use differences.
If proposing home IPC in addition to anticoagulation, provide rationale and evidence supporting expected incremental benefit.
Document plans for monitoring and support to address differences between inpatient and home settings.

Denial Risk
Compliance and cost concerns
Compliance and cost concerns — Patient adherence after discharge and high device cost may affect coverage decisions; include documentation addressing compliance support and cost-effectiveness where possible.
Describe post‑discharge support (home visits, caregiver assistance) to improve adherence.
If cost is a concern, provide rationale for device selection (purchase vs rental, portable vs nonportable) and expected duration of need.

Step Therapy
Device selection sequencing and step therapy
Device selection and sequencing (step therapy) — Prefer nonprogrammable non-segmented or segmented devices as first-line; programmable pumps require prior documented failure of nonprogrammable devices or clear documentation of unique clinical characteristics that preclude benefit from simpler devices.
Non-segmented or segmented nonprogrammable devices generally suffice for most patients.
Programmable/self-calibrated pumps (E0652) are appropriate only after documented failure of nonprogrammable devices or when scarring/contractures prevent satisfactory treatment.
Document why a higher-complexity device is necessary.

Note
Use as adjunct to standard compression
Use as adjunct to standard compression — IPC is often evaluated as an adjunct to compression garments or multilayer bandages; document combination therapy when used together.
Describe concurrent use of compression garments or multilayer bandages and other standard therapies.
Document duration and frequency of combined treatments.

Documentation Required
Required clinical and device documentation
Required clinical and device documentation — Include clear indication, device model and clearance status, planned duration/regimen, and objective baseline measures in the medical record to support coverage.
Indication and staging (e.g., lymphedema stage) with supporting exam findings.
Device model, FDA clearance status, and HCPCS codes requested.
Planned treatment regimen (frequency, duration) and expected follow-up timeline.

Documentation Required
Supporting clinical documentation
Supporting clinical documentation — Provide baseline limb/ulcer measurements, symptom and functional status, device training/observation details, and evidence of prior conservative therapies and compliance.
Baseline limb circumference/volume and wound dimensions with dates.
Documentation of patient training/observation in device use before home discharge.
Objective evidence of prior conservative care and documented compliance (e.g., use of 30 mmHg garment).

Documentation Required
Clinical and support documentation for postsurgical home IPC
Clinical and support documentation for postsurgical home IPC — For post‑discharge prophylaxis document risk stratification, explicit contraindication to pharmacologic prophylaxis when applicable, and a plan for home support to maximize adherence.
Record postoperative VTE risk level and specific contraindications to anticoagulation.
Specify home support plan (caregiver help, home health visits, monitoring schedule).
Describe expected device wear time and follow-up assessments.

Documentation Required
Suggested documentation elements
Suggested documentation elements — Include indication, prior standard care, objective wound or limb measurements, device model and FDA clearance, HCPCS codes requested, planned duration, and follow-up evaluation schedule.
Indication and prior conservative therapies with documented compliance.
Objective pre-treatment measurements and follow-up measurement plan (e.g., at 6–12 weeks).
Device model, FDA clearance, and pump + appliance HCPCS codes (pump E0650–E0652 plus appliance E0655–E0673).

Documentation Required
Lymphedema diagnosis and assessment documentation
Lymphedema assessment and diagnosis documentation — For secondary lymphedema, document history (e.g., cancer treatment), focused physical exam with asymmetric limb measurements, exclusion of other causes, and imaging when needed for diagnostic uncertainty.
Record history consistent with secondary lymphedema (surgery, radiation, trauma).
Provide limb staging per International Society of Lymphology and objective circumference/volume measures.
Include imaging (e.g., lymphoscintigraphy, ultrasound) when diagnosis is uncertain.

Step Therapy
Programmable pumps require prior failure or special justification
Programmable pumps: special documentation and sequencing — For programmable/self-calibrated pumps, document prior trial and failure of nonprogrammable devices or specific clinical features (e.g., extensive scarring, fibrosis, contractures) that prevent adequate therapy with simpler devices.
Provide documentation of nonprogrammable device trial duration and objective lack of benefit.
Describe unique clinical characteristics that necessitate programmable functionality.
If approved, specify why alternative devices are insufficient for safety or efficacy.

Note
Prior authorization guidance (informational)
Prior authorization guidance (informational) — CMS and society guidance (e.g., CMS NCD 280.6, ACCP, ASCO, ASH, NCCN) may inform prior authorization reviews but do not replace required clinical documentation; include relevant guideline citations when applicable.
Reference CMS NCD 280.6 and specialty society guidelines where relevant.
Include guideline-based rationale when proposing deviation from preferred sequencing or combining mechanical and pharmacologic prophylaxis.

Note
Documentation and submissions
Documentation and submissions — Policy history and contact information for submission of new evidence or enquiries are provided; submit new information to the payer medical policy analyst as listed in the policy history.
Mail new information or technology updates to the payer's medical policy analyst at the address in the policy history.
Include full citations and supporting documentation with any prior authorization requests.

Medical Necessity Determinations for DME

inv-109: Lymphedema equipment necessity — top-level node

Lymphedema equipment necessity: Four-week trial of conservative therapy with documented compliance to compression garment (30 mmHg), exercise, elevation; no significant improvement by circumference measures; persisting significant symptoms.4 weeks; 30 mmHg

inv-110: Programmable pump necessity — top-level node

Programmable pump necessity: Failure of nonprogrammable device therapy OR unique anatomic/clinical characteristics preventing use of nonprogrammable pumps (eg, scarring, fibrosis, contractures).

Small subset of individuals.

inv-111: Postsurgical IPC necessity — top-level node

Postsurgical IPC necessity: Contraindication to pharmacologic agents AND surgery type or presence of moderate/high VTE risk factors (eg, major orthopedic surgery or other major surgery with specified risk factors).contraindication to anticoagulation

ACCP guidance cited for bleeding risk assessment.

inv-112: DME medical necessity criteria

Medical necessity considerations for PCPs as described:

Lymphedema adjunctive use: Individuals with lymphedema who have failed conservative measures (elevation, compression garments/bandages, manual lymphatic drainage) may use PCPs as an adjunct or alternative to self-manual lymphatic drainage.

Supported by management and treatment guidance.

Venous ulcer adjunctive use: PCPs may be used to supplement standard compression therapy and conservative measures for venous ulcers.

Supported by venous ulcer management statement.

VTE prophylaxis candidate: Individuals undergoing major orthopedic surgery who cannot receive pharmacologic prophylaxis due to contraindications or bleeding risk may use intermittent limb compression devices for thromboprophylaxis.

ACCP guidance cited.

inv-113: DME medical necessity criteria — 3 top-level nodes

Home IPC for post-discharge VTE prophylaxis: Patient undergoing major orthopedic surgery or nonorthopedic surgery with elevated VTE risk; pharmacologic prophylaxis provided or contraindicated; portable battery-operated IPC recommended for home use with documentation of planned usage (eg, ~18 hours/day) and device clearance.planned home use documented

ACCP recommends portable devices for home due to compliance benefits.

IPC for venous ulcer treatment: Patient with venous leg ulcer receiving standard compression therapy; IPC may be considered as adjunct when trials suggest possible incremental healing benefit; document wound size, prior treatments, and planned IPC regimen and follow-up.follow-up >= 6 weeks

Evidence mixed; IPC often studied combined with continuous compression.

Pneumatic pumps for head/neck lymphedema: Patient with head/neck lymphedema who failed conservative therapy; document failure of manual lymphatic drainage or complete decongestive therapy and rationale for pneumatic pump use; follow-up of 6 weeks to 6 months desirable to assess outcomes.

inv-114: DME-specific medical necessity — single top-level node

DME necessity: 1) Patient has clinically confirmed lymphedema; 2) Conservative therapy has been attempted and documented as unsuccessful or not feasible; 3) PCP is intended as alternative or adjunct to existing therapies; 4) Adequate documentation of baseline measurements and plan for follow-up to assess outcomes is provided.

Based on clinical context and PICO in document.

inv-115: Lymphedema DME necessity

Medical necessity for lymphedema devices requires:

Prerequisites: Documented lymphedema; failed conservative therapy (compression garments, exercise, elevation, manual lymphatic drainage); clear treatment plan and objective baseline measurements; clinician justification for limb+truncal device if requested instead of limb-only.

RCT evidence does not consistently show benefit for truncal treatment vs limb-only.

inv-116: VTE prophylaxis DME necessity

Medical necessity for postoperative VTE prophylaxis devices requires:

Post-discharge IPC: Either (a) patient has contraindication to pharmacologic prophylaxis and mechanical prophylaxis is indicated at home, or (b) exceptional documented justification for home IPC adjunctive to pharmacologic agents despite lack of RCT evidence for incremental benefit.

In-hospital evidence supports IPC plus pharmacologic prophylaxis, but post-discharge benefit is unproven; documentation must address this evidence gap.

inv-117: DME medical necessity criteria for home IPC

Medical necessity for home IPC for VTE prophylaxis requires:

Necessity nodes: (1) patient at moderate-to-high post-surgical VTE risk; (2) clear contraindication to pharmacologic prophylaxis; (3) clinical plan for home use including measures to support compliance (eg, home visits) or other documented feasibility measures.

Supported by one RCT demonstrating reduced VTE with post-discharge IPC when accompanied by home visits

inv-118: DME medical necessity considerations

Evidence‑informed considerations for medical necessity determinations:

DFU or ischemic ulcers: Consider IPC/PCD as adjunctive therapy when high‑quality RCT evidence shows improved time to healing and when standard wound care has been and continues to be provided; document expected compliance and monitor healing outcomes.

Evidence limited; use primarily when supportive documentation present

Postoperative edema after femoropopliteal bypass: Prefer class I compression stockings over IPC as RCT evidence showed superiority of stockings for edema prevention/treatment.

Stockings recommended

RLS: Consider trial use of PCDs only with documentation and expectation of re‑evaluation given small positive RCT data and need for validation.

Limited evidence

Stroke DVT prevention:

inv-119: DME medical necessity criteria

Medical necessity may be supported when:

IPC for surgical prophylaxis: Patient undergoing major orthopedic or other major surgery with documented VTE risk where IPC is recommended by guidelines as adjunct or when pharmacologic prophylaxis is contraindicated; duration and setting (inpatient vs post-discharge) should align with guideline recommendations.

ACCP, ACOG, ASH

IPC for lymphedema: Patient has diagnosed lymphedema, has been referred to/assessed by certified lymphedema therapist or qualified clinician, and pneumatic compression is part of an ongoing home management plan documented by therapist/clinician.

NCCN, American Venous Forum, UIP

IPC for venous ulcers: Used when standard compression therapy cannot be used, has failed, or is unavailable; documentation that other compression interventions were attempted or are contraindicated is required.

SVS/AVF, Wound Healing Society

inv-120: Indications per cited guidelines

Guideline-derived situations where IPC may be indicated

When to consider IPC: When other compression options are unavailable, cannot be used, or have failed after prolonged therapy; or when patients cannot or will not use an adequate compression dressing system.

Item	Rule
Pneumatic compression pumps
rental \| purchase

Item	Rule
IPC devices cleared for home use
rental \| purchase \| capped_rental

Item	Rule / Note
APCDs / IPC pumps provided to study participants for home use
Studies described provision of devices to participants for home use; no explicit rental vs purchase rules are provided in the cited excerpts

Item	Rule
Pneumatic compression systems (limb-only or limb+trunk)
rental

Item	Rule
portable battery-operated IPC
rental \| purchase

Item	Rule
intermittent pneumatic compression pumps
rental

Item	Rule
IPC / pneumatic compression devices
rental \| purchase \| capped_rental

Item	Rule / Note
pneumatic compression devices (CMS NCD 280.6 referenced)
CMS NCD 280.6 is referenced as informational and may contain rental/purchase guidance; no explicit rental/purchase rule is provided in the cited excerpt

Item	Rule
(placeholder)

Not Covered / Investigational Uses

Summary: Cooling devices and many non‑standard uses of pneumatic compression in the home setting are categorized as investigational. The policy explicitly lists multiple investigational indications (including diabetic neuropathic ulcers, peripheral arterial disease, truncal/chest therapy, head/neck in many contexts, and venous ulcers) because current evidence is insufficient to demonstrate improved net health outcomes.

Duplicate note: The policy reiterates that cooling devices and other non‑standard home uses of pneumatic compression are considered investigational, with a list of specific indications cited where evidence is inadequate to support coverage.

The policy does not support routine provision of programmable/gradient (more complex) pumps when a nonprogrammable non‑segmented or segmented device would meet clinical needs. Programmable devices are reserved for cases with documented anatomic or clinical reasons (eg, contractures, extensive scarring) preventing effective use of simpler devices.

Placeholder: No additional not‑covered items are specified in the provided excerpts beyond the investigational categories and the device‑specific limitations already noted.

Placeholder: The document excerpts do not list further explicit equipment exclusions; investigational indications and evidence limitations are emphasized instead.

The excerpts do not identify a specific, separate list of not‑covered equipment items. For head/neck APCD applications the evidence limitations and mixed results are called out and may limit coverage in many circumstances.

Routine provision of truncal/chest treatment devices solely on the assumption of incremental benefit over limb‑only pumps is not supported by the evidence and is therefore not routinely covered without documented justification showing medical necessity.

Home IPC provided solely by extrapolation from inpatient studies—without patient‑specific justification or documented plan to ensure home adherence/support (eg, home visits)—is not supported and may be denied when requested as an adjunct to pharmacologic prophylaxis without supporting post‑discharge evidence.

Compression modalities for diabetic foot ulcers beyond IPC and compressed air massage are not supported by the evidence in these excerpts; many home‑use compression interventions for DFU lack adequate data and thus are not covered outside the limited, studied modalities.

Placeholder: No further not‑covered statements are present in the provided excerpts beyond investigational lists and evidence‑driven restrictions.

The provided document portion does not list specific DME items that are categorically non‑covered; instead, HCPCS codes for pumps and appliances are listed for billing and the text focuses on investigational indications and evidence limitations.

No explicit not‑covered DME items are listed in these chunks; the policy emphasizes investigational indications and clinical justification rather than enumerating additional excluded equipment.

Definitions and Device Types

Pneumatic compression pump definition (single vs multi-chamber devices)

Definition (general)Device that applies intermittent or continuous limb compression (single-chamber or multichamber) to mobilize fluid and reduce edema

Single vs multi-chamberSingle-chamber (non-segmented) inflates as one chamber; multi-chamber (segmented) inflates sequentially across compartments

Clinical purposeUsed for lymphedema management, venous ulcer adjunctive therapy, and postsurgical VTE prophylaxis in home setting

Contraindication to pharmacologic prophylaxis — definition and examples

DefinitionClinical situations with high bleeding risk or intolerance to anticoagulants where anticoagulation is not appropriate

Examples of risk factorsAge >65, prior bleeding, cancer, renal/liver failure, thrombocytopenia, prior stroke, antiplatelet therapy, anemia, recent surgery

ImplicationContraindication to pharmacologic prophylaxis may justify use of mechanical prophylaxis such as home IPC

Single chamber (non-segmented) non-programmable pump — device definition (E0650)

HCPCS codeE0650 — Pneumatic compressor, nonsegmental home model

Device descriptionSingle chamber (non-segmented) non-programmable pump that inflates at one time applying uniform pressure

Typical useSimplest pump type; generally sufficient for most individuals unless special anatomic issues

Multi-chamber (segmented) non-programmable pump — device definition (E0651)

HCPCS codeE0651 — Pneumatic compressor, segmental home model without calibrated gradient pressure

Device descriptionMulti-chamber (segmented) non-programmable pump with sequential inflation and fixed compartment pressures

Appliance pairingUsed with segmental appliance codes (e.g., E0667–E0669)

Programmable (segmental) pump — definition (E0652)

HCPCS codeE0652 — Pneumatic compressor, segmental home model with calibrated gradient pressure

Device descriptionProgrammable (segmental) pump allowing manual adjustment of individual compartment pressure and/or inflation cycle parameters

IndicationReserved for patients with contractures, extensive scarring, or sensitive skin when non-programmable pumps are inadequate

PE definition — Pulmonary embolism

DefinitionPulmonary embolism (PE): migration of a detached DVT clot to the lungs that can be fatal

Clinical relevancePE is a principal serious consequence of DVT motivating prophylaxis strategies

ContextDiscussed in relation to high DVT rates after major orthopedic surgery without prophylaxis

IPC definition — mechanical limb compression device for VTE risk reduction or ulcer healing

DefinitionIntermittent pneumatic compression (IPC): a mechanical limb compression device, frequently portable and battery-operated for home use, used to reduce VTE risk or aid venous/lymphatic ulcer healing

Typical featuresSleeves or foot devices applying cyclic compression to enhance blood flow and reduce edema

Use casesVTE prophylaxis, lymphedema adjunct therapy, venous ulcer adjunctive care

Pneumatic compression pumps (PCPs / IPC / APCD) — device category definition

Category definitionPneumatic compression pumps (PCPs / IPC / APCD): devices with inflatable garments and a pump applying intermittent or advanced pneumatic compression to limbs and sometimes trunk/head/neck

IncludesSingle-chamber, multi-chamber, programmable APCDs (e.g., Flexitouch) and associated appliances/sleeves

Intended effectsMobilize interstitial/lymphatic fluid, reduce edema, and decrease venous stasis

Pneumatic compression pump / IPC device — device definition

Device definitionPneumatic compression pump / IPC device: device applying intermittent pneumatic pressure via garments to limbs (optionally chest/trunk) to move interstitial fluid or reduce venous stasis

ApplicationsLymphedema therapy, venous ulcer adjunct, postoperative VTE prophylaxis

Home useMany devices are designed/cleared for home use with appropriate training

Home IPC — home use definition

DefinitionHome IPC: prescription and use of a limb compression device in the home setting following training and with a documented plan for use

ConsiderationsDocumentation should show feasibility, support for compliance (eg, home visits) when indicated by evidence

Device characteristicsPrefer portable, battery-operated devices for home thromboprophylaxis

Moderate-to-high postsurgical VTE risk — definition

DefinitionModerate-to-high postsurgical VTE risk: surgical patients with Caprini scores or other risk factors estimating symptomatic VTE risk around ~3% (moderate) to ~6% (high)

Use implicationPatients at this risk may require pharmacologic prophylaxis or mechanical prophylaxis if pharmacologic agents are contraindicated

ExamplesMajor orthopedic surgery, abdominal-pelvic cancer surgery, multiple patient risk factors

Intermittent pneumatic compression (IPC) — therapy definition (leaf)

DefinitionIntermittent pneumatic compression (IPC): therapy applying cyclic compression to a limb (via sleeves or foot devices) to enhance blood flow, reduce edema, and potentially improve wound healing and DVT prevention

Typical regimenVaries by indication; examples include 1 hour twice daily for venous ulcers or device-specific session lengths

Clinical outcomesMeasured outcomes include symptom relief, limb volume reduction, wound healing, and prevention of DVT

Extended-duration prophylaxis — definition

DefinitionExtended-duration prophylaxis: prolonged prophylaxis beyond inpatient period (eg, 4 weeks recommended for certain high-risk cancer abdominal/pelvic surgery patients)

ContextGuideline-specified for select high-risk surgical populations

DocumentationExpected duration should be documented when requesting home devices for extended prophylaxis

VTE risk categories — very low/low/moderate/high definitions and approximate risks

Very low risk<0.5% — recommend early ambulation only

Low risk~1.5% — mechanical prophylaxis suggested over no prophylaxis

Moderate risk~3% — pharmacologic or mechanical prophylaxis suggested (if not at high bleeding risk)

IPC definition (redundant entry) — device-based compression therapy applied intermittently

IPC definition (redundant)Device-based compression therapy applied intermittently (sequential or cyclical) to limbs or trunk to improve lymphatic or venous flow

Clinical roleSuggested when other compression options unavailable or failed; can be used with or without compression dressings for venous ulcers

Guideline basisStatements derived from SVS/AVF and Wound Healing Society guidance

Pneumatic compressor (home model) — HCPCS E0650-E0652 and related appliance codes

HCPCS listingHome pneumatic compressors uses HCPCS E0650–E0652 and multiple appliance codes (E0655–E0673) per policy codes table

Device codingE0650 = nonsegmental; E0651 = segmental nonprogrammable; E0652 = segmental programmable with gradient pressure

Appliance codesAppliance codes correspond to limb/arm/leg/trunk/head configurations as listed in HCPCS table

OpenPayer

Pneumatic Compression Devices in the Home Setting

Coverage and Medical Necessity Criteria

HCPCS and Coding Guidance

Prior Authorization, Documentation, and Billing Actions

Medical Necessity Determinations for DME

Rental, Purchase, and Capped Rental Guidance

Replacement and Accessory Guidance

Required Clinical Documentation

Not Covered / Investigational Uses

Background and Rationale

Definitions and Device Types

Policy History and Revisions